A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Clinical risk prediction, coronary computed tomography angiography, and cardiovascular events in new-onset chest pain: the PROMISE and SCOT-HEART trials
Tekijät: Rasmussen, Laust Dupont; Schmidt, Samuel Emil; Knuuti, Juhani; Vrints, Christiaan; Bøttcher, Morten; Foldyna, Borek; Williams, Michelle C.; Newby, David E.; Douglas, Pamela S.; Winther, Simon
Kustantaja: Oxford University Press
Julkaisuvuosi: 2024
Journal: European Heart Journal
Tietokannassa oleva lehden nimi: European heart journal
Lehden akronyymi: Eur Heart J
Vuosikerta: 46
Numero: 5
Aloitussivu: 473
Lopetussivu: 483
ISSN: 0195-668X
eISSN: 1522-9645
DOI: https://doi.org/10.1093/eurheartj/ehae742
Verkko-osoite: https://doi.org/10.1093/eurheartj/ehae742
BACKGROUND AND AIMS: Whether index testing using coronary computed tomography angiography (CTA) improves outcomes in stable chest pain is debated. The risk factor weighted clinical likelihood (RF-CL) model provides likelihood estimation of obstructive coronary artery disease. This study investigated the prognostic effect of coronary CTA vs. usual care by RF-CL estimates.
METHODS: Large-scale studies randomized patients (N = 13 748) with stable chest pain to coronary CTA as part of the initial work-up in addition to or instead of usual care including functional testing. Patients were stratified according to RF-CL estimates [RF-CL: very-low (≤5%), low (>5%-15%), and moderate/high (>15%)]. The primary endpoint was myocardial infarction or death at 3 years.
RESULTS: The primary endpoint occurred in 313 (2.3%) patients. Event rates were similar in patients allocated to coronary CTA vs. usual care [risk difference (RD) 0.3%, hazard ratio (HR) 0.84 (95% CI 0.67-1.05)]. Overall, 33%, 44%, and 23% patients had very-low, low, and moderate/high RF-CL. Risk was similar in patients with very low and moderate/high RF-CL allocated to coronary CTA vs. usual care [very low: RD 0.3%, HR 1.27 (0.74-2.16); moderate/high: RD 0.5%, HR 0.88 (0.63-1.23)]. Conversely, patients with low RF-CL undergoing coronary CTA had lower event rates [RD 0.7%, HR 0.67 (95% CI 0.47-0.97)]. The number needed to test using coronary CTA to prevent one event within 3 years was 143.
CONCLUSIONS: Despite an overall good prognosis, low RF-CL patients have reduced risk of myocardial infarction or death when allocated to coronary CTA vs. usual care. Risk is similar in patients with very-low and moderate/high likelihood.
Julkaisussa olevat rahoitustiedot:
Danish Cardiovascular Academy (PD5Y-2023001-DCA to L.D.R.); Novo Nordisk Foundation (NNF20SA0067242); The Danish Heart Foundation; the British Heart Foundation (CH/09/002, RG/16/10/ 32375, and RE/18/5/34216 to D.E.N.); Novo Nordisk Foundation Clinical Emerging Investigator grant (NNF21OC0066981 to S.W.); British Heart Foundation (FS/ICRF/20/26002 to M.C.W.); Academy of Finland, Turku University Hospital-funding and Finnish Foundation for Cardiovascular Research to J.K.